Cellectis (CLLS) Tops Q4 EPS by 19c

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.54), $0.19 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $3.08 million versus the consensus estimate of $4.95 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers
• SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
• AeroVironment (AVAV) PT Lowered to $280 at Canaccord